Executive holdings
Information about Credit Suisse securities held by members of the Board of Directors and the Executive Board.
-
Board of Directors
The following table discloses the shareholdings of the Board members, their immediate family and companies in which they have a controlling interest. As of December 31, 2021 and 2020, there were no Board members with outstanding options.
Any dealings in CSG Securities are published promptly in line with the SIX Directive on the Disclosure of Management Transactions on the SIX website as well as on the Credit Suisse Group website.
December 31 (shares)1 2021 2020 Axel Lehmann 2
108,220 –
António Horta-Osório 3 335,902 – Iris Bohnet 115,182 96,328 Clare Brady 2 12,695 – Juan Colombas 2,4 – – Christian Gellerstad 138,884 103,991 Michael Klein 71,465 49,897 Shan Li 49,062 28,590 Seraina Macia 105,035 84,844 Blythe Masters 2 12,027 – Richard Meddings 58,403 13,774 Kai S. Nargolwala 422,140 366,334 Ana Paula Pessoa 79,404 53,816 Severin Schwan 199,154 169,976 Total 1,707,573 967,550 5
1 Includes Group shares that are subject to a blocking period of up to four years; includes shareholdings of immediate family members.
2 Clare Brady and Blythe Masters were newly elected at the 2021 AGM. Juan Colombas and Axel Lehmann were newly elected at the EGM on October 1, 2021.
3 Chairman and Board member until January 16, 2022.
4 Juan Colombas will receive the share portion of his Board and Committee fees at the end of the 2021/2022 Board period.
5 Excludes 425,783 shares held by Urs Rohner, 104,659 shares held by Andreas Gottschling, 77,724 shares held by Joaquin J. Ribeiro and 335,960 shares held by John Tiner, who did not stand for re-election to the Board as of April 30, 2021.
-
Executive Board
Executive Board holdings and values of deferred share-based awards by individual.
Any dealings in CSG Securities are published promptly in line with the SIX Directive on the Disclosure of Management Transactions on the SIX website as well as on the Credit Suisse Group website.
December 31, 2021
Individual Number
of owned
shares1Number of
unvested awards2Number of
owned shares
and unvested awardsValue (CHF) of
unvested awards
at grant date3Value (CHF) of
unvested awards
at year end
(at fair value)4Thomas P. Gottstein
343,933
865,241
1,209,174
10,346,761
5,044,803
Romeo Cerutti
419,333
339,027
758,360
4,074,902
2,033,172
André Helfenstein
89,962
516,222
606,184
5,574,001
3,215,381
Lydie Hudson
–
243,816
243,816
2,670,588
1,383,393
Ulrich Körner 246,487 – 246,487 – – Rafael Lopez Lorenzo 99,591 127,566 227,157 1,519,990 1,131,766 David R. Mathers
163,403
992,083
1,155,486
10,869,369
6,974,651
Christian Meissner 247 – 247 – – Joachim Oechslin 213,577 272,122 485,699 3,506,175 2,414,266 Antoinette Poschung
158,585
123,557
282,142
1,355,032
706,324
Helman Sitohang
471,033
805,946
1,276,979
9,665,696
4,811,141
James B. Walker
221,384
396,582
617,966
4,314,624
2,582,473
Philipp Wehle
76,739
549,634
626,373
6,208,945
3,511,812
Total 2,504,274
5,231,796
7,736,070
60,106,082
33,809,182
1 Includes shares that were initially granted as deferred compensation and have vested.
2 Includes unvested shares originating from LTI opportunities calculated on the basis of maximum opportunity for awards that have not reached the end of their three-year performance period, given that the actual achievement level and associated number of unvested shares cannot be determined until the end of the performance period. For LTI awards that have reached the end of their three-year performance period, the number of unvested shares reflects the actual number of shares earned based on achievement of the performance target levels.
3 Determined based on the number of unvested awards multiplied by the share price at grant.
4 Includes the value of unvested LTI opportunities. For LTI awards that have reached the end of their three-year performance period, the value is based on the actual number of shares eligible to vest. For LTI opportunities that have not reached the end of their three-year performance period, this is determined based on the number of shares at fair value at the time of grant, multiplied by the share price at the end of the year.
December 31, 2020
Individual Number
of owned
shares1Number of
unvested awards2Number of
owned shares
and unvested awardsValue (CHF) of
unvested awards
at grant date3Value (CHF) of
unvested awards
at year end
(at fair value)4Thomas P. Gottstein
329,945
1,175,386
1,505,331
14,059,196
7,982,209
Romeo Cerutti
360,449
569,438
929,887
7,134,274
4,108,232
Brian Chin
568,030
1,790,864
2,358,894
21,951,346
12,474,970
André Helfenstein
74,229
671,329
745,558
7,523,347
5,899,796
Lydie Hudson
57,115
421,216
478,331
4,864,351
2,895,168
David R. Mathers
110,958
1,313,581
1,424,539
14,661,244
10,505,639
Antoinette Poschung
141,405
207,515
348,920
2,360,009
1,412,321
Helman Sitohang
365,186
1,344,933
1,710,119
16,773,304
9,612,195
James B. Walker
143,444
577,046
720,490
6,552,588
5,092,395
Lara J. Warner
–
1,089,006
1,089,006
13,461,484
7,647,962
Philipp Wehle
74,542
670,246
744,788
7,652,671
5,095,777
Total 2,225,303
9,830,560
12,055,863
116,993,815
72,726,662
1 Includes shares that were initially granted as deferred compensation and have vested.
2 Includes unvested shares originating from LTI opportunities calculated on the basis of maximum opportunity for awards that have not reached the end of their three-year performance period, given that the actual achievement level and associated number of unvested shares cannot be determined until the end of the performance period. For LTI awards that have reached the end of their three-year performance period, the number of unvested shares reflects the actual number of shares earned based on achievement of the performance target levels.
3 Determined based on the number of unvested awards multiplied by the share price at grant.
4 Includes the value of unvested LTI opportunities. For LTI awards that have reached the end of their three-year performance period, the value is based on the actual number of shares eligible to vest. For LTI opportunities that have not reached the end of their three-year performance period, this is determined based on the number of shares at fair value at the time of grant, multiplied by the share price at the end of the year.
